Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8255 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8199 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.811 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7976 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8361 |
Approved |
0.764 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7635 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7558 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.717 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7069 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD2067 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7024 |
Intermediate Similarity |
NPD919 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6952 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6952 |
Remote Similarity |
NPD8319 |
Approved |
0.6951 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6951 |
Remote Similarity |
NPD3226 |
Approved |
0.695 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD2796 |
Approved |
0.6941 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6941 |
Remote Similarity |
NPD1247 |
Approved |
0.6933 |
Remote Similarity |
NPD5403 |
Approved |
0.6928 |
Remote Similarity |
NPD37 |
Approved |
0.6923 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6534 |
Approved |
0.6923 |
Remote Similarity |
NPD6535 |
Approved |
0.6914 |
Remote Similarity |
NPD5401 |
Approved |
0.691 |
Remote Similarity |
NPD6784 |
Approved |
0.691 |
Remote Similarity |
NPD6785 |
Approved |
0.6909 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD4965 |
Approved |
0.6905 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD4966 |
Approved |
0.6905 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6902 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD6858 |
Approved |
0.6901 |
Remote Similarity |
NPD7094 |
Approved |
0.6892 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6889 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6867 |
Remote Similarity |
NPD7411 |
Suspended |
0.686 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6845 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6839 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6836 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD920 |
Approved |
0.6824 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6821 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6812 |
Remote Similarity |
NPD164 |
Approved |
0.681 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD5951 |
Approved |
0.6802 |
Remote Similarity |
NPD3787 |
Discontinued |
0.68 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD8313 |
Approved |
0.6798 |
Remote Similarity |
NPD8312 |
Approved |
0.6792 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6786 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6771 |
Remote Similarity |
NPD7874 |
Approved |
0.6771 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6273 |
Approved |
0.6765 |
Remote Similarity |
NPD3749 |
Approved |
0.6763 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6738 |
Remote Similarity |
NPD6777 |
Approved |
0.6738 |
Remote Similarity |
NPD6778 |
Approved |
0.6738 |
Remote Similarity |
NPD6779 |
Approved |
0.6738 |
Remote Similarity |
NPD6776 |
Approved |
0.6738 |
Remote Similarity |
NPD6780 |
Approved |
0.6738 |
Remote Similarity |
NPD6781 |
Approved |
0.6738 |
Remote Similarity |
NPD6782 |
Approved |
0.6728 |
Remote Similarity |
NPD3887 |
Approved |
0.6726 |
Remote Similarity |
NPD1934 |
Approved |
0.6723 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD7497 |
Discontinued |
0.672 |
Remote Similarity |
NPD7697 |
Approved |
0.672 |
Remote Similarity |
NPD7698 |
Approved |
0.672 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6707 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6688 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6688 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD2801 |
Approved |
0.6685 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6685 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6684 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6684 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3748 |
Approved |
0.6667 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6648 |
Remote Similarity |
NPD7228 |
Approved |
0.6648 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6648 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6647 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD5667 |
Approved |
0.6644 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6644 |
Remote Similarity |
NPD5126 |
Approved |
0.6644 |
Remote Similarity |
NPD3317 |
Approved |
0.6642 |
Remote Similarity |
NPD1238 |
Approved |
0.6629 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD2403 |
Approved |
0.6625 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6625 |
Remote Similarity |
NPD2438 |
Suspended |
0.6623 |
Remote Similarity |
NPD3972 |
Approved |
0.662 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6606 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6605 |
Remote Similarity |
NPD2800 |
Approved |
0.6605 |
Remote Similarity |
NPD1243 |
Approved |
0.6603 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6596 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6592 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6585 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.658 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6573 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6568 |
Remote Similarity |
NPD6385 |
Approved |
0.6568 |
Remote Similarity |
NPD6386 |
Approved |
0.6564 |
Remote Similarity |
NPD7003 |
Approved |
0.6564 |
Remote Similarity |
NPD7801 |
Approved |
0.6562 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6562 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6561 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6561 |
Remote Similarity |
NPD6663 |
Approved |
0.6554 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6552 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.655 |
Remote Similarity |
NPD5353 |
Approved |
0.6549 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6538 |
Remote Similarity |
NPD7095 |
Approved |
0.6534 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD6099 |
Approved |
0.6522 |
Remote Similarity |
NPD6100 |
Approved |
0.6522
|
Remote Similarity |
NPD5405 |
Approved |